Renalytix uses cookies to improve your experience. We respect your privacy and are committed to protecting your personal data. Read Privacy Notice

Renalytix to Present at 42nd Annual William Blair Growth Stock Conference


Renalytix to Present at 42nd Annual William Blair Growth Stock Conference

NEW YORK and SALT LAKE CITY, June 08, 2022 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will present at the 42nd Annual William Blair Growth Stock Conference on Thursday, June 9 at 2:00 p.m. CT. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at

For further information, please contact:

Renalytix plc  
James McCullough, CEO Via Walbrook PR  
Stifel (Nominated Adviser, Joint Broker) Tel: 020 7710 7600  
Alex Price / Nicholas Moore    
Investec Bank plc (Joint Broker) Tel: 020 7597 4000  
Gary Clarence / Daniel Adams    
Walbrook PR Limited Tel: 020 7933 8780 or  
Paul McManus / Lianne Applegarth / Alice Woodings Mob: 07980 541 893 / 07584 391 303 / 07407 804 654  
CapComm Partners Tel: 415-389-6400 or  
Peter DeNardo    

About Renalytix 
Renalytix (NASDAQ: RNLX) (LSE: RENX) is an in-vitro diagnostics and laboratory services company that is the global founder and leader in the new field of bioprognosisTM for kidney health. The leadership team, with a combined 200+ years of healthcare and in-vitro diagnostic experience, has designed its KidneyIntelX laboratory-developed test to enable risk assessment for rapid progressive decline in kidney function in adult patients with T2D with early CKD stages 1-3. We believe that by understanding how disease will progress, patients and providers can take action early to improve outcomes and reduce overall health system costs. For more information, visit

Help Me Spread The Post

If you enjoyed this post, we’d be grateful if you would help us spread its content.

Leave a comment

We’d love to hear your thoughts about this topic or any others. Please leave your comments below.

Note: your email address will not be published.

Well Filtered™

Get access to the blog, webinars and podcasts with the ideas, perspectives and innovations that matter most in kidney health.